C07C225/06

METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):

##STR00001##

wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):

##STR00002##

wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):

##STR00001##

wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):

##STR00002##

wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):

##STR00001##

wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):

##STR00002##

wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):

##STR00001##

wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):

##STR00002##

wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):

##STR00001##

wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):

##STR00002##

wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):

##STR00001##

wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):

##STR00002##

wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

NOVEL CRYSTALLINE FORMS

Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.

NOVEL CRYSTALLINE FORMS

Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.

Method for producing kakeromycin and derivatives thereof

Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1): ##STR00001##
wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2): ##STR00002##
wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.

METHOD FOR FORMING THREE-DIMENSIONAL OBJECT

The present invention relates to a method for forming a three-dimensional object; according to the present invention, when the three-dimensional object is manufactured by an inkjet method, a support can be removed without damage to a structure body such that the three-dimensional object can be simply and economically manufactured.